These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1185573)

  • 1. GLC determination of 7-chloro-5,11-dihydrodibenz[b,e][1,4]-oxazepine-5-carboxamide in serum or plasma.
    Niedermayer AO; Koski RG
    J Pharm Sci; 1975 Sep; 64(9):1531-4. PubMed ID: 1185573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis for carbamazepine in serum by electron-capture gas chromatography.
    Schwertner HA; Hamilton HE; Wallace JE
    Clin Chem; 1978 Jun; 24(6):895-9. PubMed ID: 657479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of loxapine in human plasma and urine and identification of three urinary metabolites.
    Cooper SF; Dugal R; Bertrand MJ
    Xenobiotica; 1979 Jul; 9(7):405-14. PubMed ID: 494666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GLC analysis of loxapine, amoxapine, and their metabolites in serum and urine.
    Cooper TB; Kelly RG
    J Pharm Sci; 1979 Feb; 68(2):216-9. PubMed ID: 423094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical characterization and activity in vivo of polymorphic forms of 7-chloro-5, 11-dihydrodibenz[b, e][1, 4]oxazepine-5-carboxamide, a potential tricyclic antidepressant.
    Gibbs IS; Heald A; Jacobson H; Wadke D; Weliky I
    J Pharm Sci; 1976 Sep; 65(9):1380-5. PubMed ID: 966158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolism of dibenz[b,f]-1,4-oxazepine (CR): in vivo hydroxylation of 10,11-dihydrodibenz[b,f]-1,4-oxazepin-11-(1OH)-one and the NIH shift.
    Harrison JM; Clarke RJ; Inch TD; Upshall DG
    Experientia; 1978 Jun; 34(6):698-9. PubMed ID: 658275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fate of dibenz[b,f]-1,4-oxazepine (CR) in the rat, rhesus monkey and guinea-pig. Part I. Metabolism in vivo.
    French MC; Harrison JM; Inch TD; Leadbeater L; Newman J; Upshall DG; Powell GM
    Xenobiotica; 1983 Jun; 13(6):345-59. PubMed ID: 6636831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel polycyclic heterocycles. IV. Structure of the dimer of 5,11-dihydrodibenz[b,e][1,4]oxazepine. Infrared, proton magnetic resonance, and mass spectral studies.
    Yale HL; Sowinski F
    J Med Chem; 1967 Nov; 10(6):1022-5. PubMed ID: 6056026
    [No Abstract]   [Full Text] [Related]  

  • 9. Determination of therapeutic and toxic concentrations of doxepin and loxapine using gas-liquid chromatography with a nitrogen-sensitive detector, and gas chromatography-mass spectrometry of loxapine.
    Vasiliades J; Sahawneh TM; Owens C
    J Chromatogr; 1979 Dec; 164(4):457-70. PubMed ID: 541421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of prostaglandin E2 by 1-acetyl-2-(8-chloro-10,11-dihydrodibenz (b,f) (1,4) oxazepine-10-carbonyl) hydrazine (SC-19220).
    Sanner JH
    Arch Int Pharmacodyn Ther; 1969 Jul; 180(1):46-56. PubMed ID: 4982414
    [No Abstract]   [Full Text] [Related]  

  • 11. Microbial transformation of 8-chloro-10,11-dihydrodibenz(b,f)(1,4)oxazepine by fungi.
    Jiu J; Mizuba S; Hribar J
    Appl Environ Microbiol; 1977 Jan; 33(1):26-30. PubMed ID: 836023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GLC determination of underivatized carbamazepine in whole blood.
    Sheehan M; Beam RE
    J Pharm Sci; 1975 Dec; 64(12):2004-6. PubMed ID: 1206497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GLC identification and determination of 3,4-methylenedioxyamphetamine (MDA) from plasma and urine.
    Midha KK; McGilveray IJ; Bhatnagar SP; Cooper JK
    J Pharm Sci; 1976 Feb; 65(2):188-97. PubMed ID: 1255447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific and sensitive method for the determination of tobanum using gas chromatography with electron-capture and mass fragmentographic detection.
    Tomori E; Elekes I
    J Chromatogr; 1981 Jan; 204():355-60. PubMed ID: 6111567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GLC/MS assay for loxapine in human biofluids and tissues with deuterium labeled analog as an internal standard.
    Lutz T; Jindal SP; Cooper TB
    J Anal Toxicol; 1982; 6(6):301-4. PubMed ID: 7162141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GLC analysis of lidocaine in plasma using a novel nitrogen-sensitive detector.
    Hucker HB; Stauffer SC
    J Pharm Sci; 1976 Jun; 65(6):926-7. PubMed ID: 932985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative determination of phenacetin and its metabolite acetaminophen by GLC-chemical ionization mass spectrometry.
    Garland WA; Hsiao KC; Pantuck EJ; Conney AH
    J Pharm Sci; 1977 Mar; 66(3):340-4. PubMed ID: 845798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of imidazobenzodiazepine-3-carboxamide, a new anxiolytic agent, in human plasma by gas chromatography--negative chemical-ionization mass spectrometry.
    Rubio F; Miwa BJ; Garland WA
    J Chromatogr; 1982 Dec; 233():167-73. PubMed ID: 6131077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of blood and tissue for amoxapine and trimipramine.
    Wu Chen NB; Schaffer MI; Lin RL; Hadac JP; Stein RJ
    J Forensic Sci; 1983 Jan; 28(1):116-21. PubMed ID: 6680730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GLC determination of ethinamate and its hydroxy derivative in biological fluids.
    Kleber JW; Bechtol LD; Brunson MK; Chernish SM
    J Pharm Sci; 1977 Jul; 66(7):992-4. PubMed ID: 560472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.